Clinical Trial Update: A Study of the Safety, Effectiveness and Clinical Use of Maviret in Adolescent Patients With Chronic Hepatitis C Virus

View source ↗

Summary

This clinical trial update reports on the safety and effectiveness of Maviret (glecaprevir/pibrentasvir) in adolescent patients with chronic hepatitis C infecti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Maviret (glecaprevir/pibrentasvir)

Snippet

Sponsor: AbbVie | Conditions: Hepatitis C Virus (HCV) | Status: COMPLETED